Immunotherapy in resistant cancer : from the lab bench work to its clinical perspectives /
Saved in:
Imprint: | Amsterdam : Academic Press, 2021. |
---|---|
Description: | 1 online resource. |
Language: | English |
Series: | Sensitizing agents for cancer resistant to cell mediated immunotherapy Sensitizing agents for cancer resistant to cell mediated immunotherapy. |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/12518925 |
MARC
LEADER | 00000cam a22000001i 4500 | ||
---|---|---|---|
001 | 12518925 | ||
005 | 20210226175815.9 | ||
006 | m d | ||
007 | cr ||||||||||| | ||
008 | 200817s2021 ne o 000 0 eng d | ||
015 | |a GBC0C5424 |2 bnb | ||
019 | |a 1198974875 | ||
020 | |a 9780128220290 |q (ePub ebook) | ||
020 | |a 0128220295 |q (ePub ebook) | ||
020 | |z 9780128220283 |q (hbk.) | ||
020 | |z 0128220287 | ||
035 | |a (OCoLC)1203029014 |z (OCoLC)1198974875 | ||
035 | 9 | |a (OCLCCM-CC)1203029014 | |
037 | |a 9780128220290 |b Ingram Content Group | ||
040 | |a UKMGB |b eng |e rda |e pn |c UKMGB |d OCLCO |d UKAHL |d YDX |d OCLCF |d OPELS |d ABC |d OCLCO | ||
049 | |a MAIN | ||
050 | 4 | |a RC271.I45 | |
245 | 0 | 0 | |a Immunotherapy in resistant cancer : |b from the lab bench work to its clinical perspectives / |c edited by Jorge Morales Montor, Mariana Segovia. |
264 | 1 | |a Amsterdam : |b Academic Press, |c 2021. | |
300 | |a 1 online resource. | ||
336 | |a text |2 rdacontent | ||
337 | |a computer |2 rdamedia | ||
338 | |a online resource |2 rdacarrier | ||
490 | 1 | |a Sensitizing agents for cancer resistant to cell mediated immunotherapy | |
500 | |a 1. Introduction to immunotherapy: History of immune therapy in cancer<br>2. Infiltrating immune mass in cancer: what is beyond T lymphocytes<br>3. Immunotherapy and macrophages <br>4. Immune checkpoints in different types of cancer: Where and when<br>5. Immune cocktails in solid tumors<br>6. Immunotherapy as adjuvant modality<br>7. Immuno-phenotyping as a diagnosis in cancer: Is it useful in pathology? <br>8. Immunoresistance: Basic and clinical data<br>9. Glycosylation: Implications for resistance to immune therapy. | ||
588 | |a Description based on CIP data; resource not viewed. | ||
650 | 0 | |a Cancer |x Immunotherapy. |0 http://id.loc.gov/authorities/subjects/sh87002642 | |
650 | 2 | |a Neoplasms |x therapy. |0 https://id.nlm.nih.gov/mesh/D009369Q000628 | |
650 | 2 | |a Immunotherapy. |0 https://id.nlm.nih.gov/mesh/D007167 | |
650 | 7 | |a Cancer |x Immunotherapy. |2 fast |0 (OCoLC)fst00845386 | |
655 | 4 | |a Electronic books. | |
700 | 1 | |a Morales Montor, Jorge, |e editor. | |
700 | 1 | |a Segovia, Mariana, |e editor. | |
776 | 0 | 8 | |i Print version : |z 9780128220283 |
830 | 0 | |a Sensitizing agents for cancer resistant to cell mediated immunotherapy. | |
903 | |a HeVa | ||
929 | |a oclccm | ||
999 | f | f | |i 50217dee-d6c0-5dfa-8dab-bf96acda68ed |s 68295ee2-674e-56b3-9584-0a87b4c1eb28 |
928 | |t Library of Congress classification |a RC271.I45 |l Online |c UC-FullText |u https://www.sciencedirect.com/science/book/9780128220283 |z Elsevier |g ebooks |i 12168112 |